机构：特朗普拟降低药价 制药股面临抛售压力

Core Viewpoint - The announcement by Trump regarding plans to lower prescription drug prices in the U.S. is expected to create selling pressure on pharmaceutical stocks [1] Group 1: Impact on Pharmaceutical Companies - Pharmaceutical stocks in the U.S. may face significant selling pressure following Trump's announcement [1] - If Trump implements price caps on drug imports instead of tariffs, it could have a major impact on pharmaceutical companies and their profits [1]